Percheron Therapeutics (AU:PER) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Percheron Therapeutics has reported a change in the director’s interest, with Director James Garner acquiring 125,000 additional fully paid ordinary shares, increasing his total to 1.5 million shares. This acquisition, valued at $8,937.50, was done through on-market purchases, reflecting potential confidence in the company’s future prospects.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
